Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Sales

IceCure Medical (ICCM) Enterprise Value (2020 - 2026)

IceCure Medical has reported Enterprise Value over the past 7 years, most recently at -$8.1 million for Q1 2026.

  • For Q1 2026, Enterprise Value fell 34.35% year-over-year to -$8.1 million; the TTM value through Mar 2026 reached -$8.1 million, down 34.35%, while the annual FY2025 figure was -$8.9 million, 17.62% down from the prior year.
  • Enterprise Value was -$8.1 million for Q1 2026 at IceCure Medical, up from -$8.9 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$6.0 million in Q1 2025 and bottomed at -$24.0 million in Q4 2022.
  • The 5-year median for Enterprise Value is -$8.5 million (2025), against an average of -$10.9 million.
  • Year-over-year, Enterprise Value skyrocketed 53.82% in 2023 and then tumbled 34.35% in 2026.
  • Over 5 years, Enterprise Value stood at -$24.0 million in 2022, then skyrocketed by 53.82% to -$11.1 million in 2023, then soared by 31.62% to -$7.6 million in 2024, then dropped by 17.62% to -$8.9 million in 2025, then rose by 8.79% to -$8.1 million in 2026.
  • The last three reported values for Enterprise Value were -$8.1 million (Q1 2026), -$8.9 million (Q4 2025), and -$6.0 million (Q1 2025) per Business Quant data.